mezagitamab, an investigational anti-CD38 antibody providing rapid, selective and sustained depletion of disease-causing ...

Krystal Biotech ( (KRYS) ) just unveiled an announcement.

A provisional cause of death, provided by pathologists Dr Michael Parsons and Jens Stahlschmidt, was given as 1a, multiple ...

Police have launched an investigation following the sudden death of a schoolgirl. Tilly Fern Wooler was rushed to hospital ...

Today’s updates include molecular data from multiple patients demonstrating SERPINA1 delivery and alpha-1 antitrypsin, AAT ... KB408 for the treatment of alzha-1 antitrypsin deficiency lung disease: ...

In 2024, startups saw a notable resurgence in large-scale funding rounds. By May, over 100 startups had secured funding ...

BEAM appoints Sravan K. Emany as its new chief financial officer, effective Dec. 19. Shares rise on this leadership transition.

It develops BEAM-101 for the treatment of sickle cell disease or beta-thalassemia; and BEAM-302, a liver-targeting LNP ...

Fintel reports that on December 6, 2024, Jefferies initiated coverage of Mereo BioPharma Group plc - Depositary Receipt () ...